Obesity First: Addressing the Causes & Consequences of Obesity
Time: 9:00 am
day: Day One
- Targeting obesity: leveraging a novel GIPR antagonist and GLP-1 receptor agonist to achieve significant reduction in body weight
- How do we maintain optionality in obesity drug development?
- Adapting to evolving needs on patient-centred obesity care